Liraglutide
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
Novo Nordisk · Phase 3 · Completed · Enrollment 422
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Lira 3.0 mg | 101 participants | 35 participants | 38 participants | n/r | n/r |
| Placebo | 36 participants | 5 participants | 26 participants | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.